Diana Cao

Diana Cao

UNVERIFIED PROFILE

Are you Diana Cao?   Register this Author

Register author
Diana Cao

Diana Cao

Publications by authors named "Diana Cao"

Are you Diana Cao?   Register this Author

14Publications

283Reads

10Profile Views

Considerations for Optimal Blood Pressure Goals in the Elderly Population: A Review of Emergent Evidence.

Pharmacotherapy 2018 03 1;38(3):370-381. Epub 2018 Feb 1.

Department of Clinical and Administrative Sciences, School of Pharmacy, Keck Graduate Institute, Claremont, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.2081DOI Listing
March 2018

Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers.

EJNMMI Res 2016 Dec 17;6(1):26. Epub 2016 Mar 17.

Tumour Targeting Laboratory, Ludwig Institute for Cancer Research and Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13550-016-0180-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796444PMC
December 2016

Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms.

Apoptosis 2015 Nov;20(11):1483-98

Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute and La Trobe University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10495-015-1166-5
Publisher Site
http://dx.doi.org/10.1007/s10495-015-1166-5DOI Listing
November 2015

Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure.

Cardiology 2014 17;128(4):333-42. Epub 2014 Jun 17.

Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, Calif., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360604DOI Listing
February 2015

Radiolabelling and evaluation of a novel sulfoxide as a PET imaging agent for tumor hypoxia.

Nucl Med Biol 2014 May-Jun;41(5):419-25. Epub 2014 Mar 12.

Centre for PET, Austin Health, Level 1 HSB, 145 Studley Road, Heidelberg VIC 3084, Australia; Ludwig Institute for Cancer Research, Melbourne - Austin Branch, Heidelberg VIC 3084, Australia; School of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne VIC 3010, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nucmedbio.2014.03.001DOI Listing
December 2014

Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008.

Clin Cancer Res 2013 Nov 17;19(21):5984-93. Epub 2013 Sep 17.

Authors' Affiliations: Tumour Targeting Laboratory and Oncogenic Transcription Laboratory, Ludwig Institute for Cancer Research; Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia; Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, Cancer Research Centre, Bethesda, Maryland; Clinical Development-Oncology, Daiichi Sankyo Pharmaceutical Development, Edison, New Jersey; and Global Project Management Department, Daiichi Sankyo Co. Ltd., Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3104DOI Listing
November 2013

Radiolabelling and evaluation of novel haloethylsulfoxides as PET imaging agents for tumor hypoxia.

Nucl Med Biol 2012 Aug 14;39(6):871-82. Epub 2012 Feb 14.

School of Chemistry and Bio21 Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nucmedbio.2012.01.004DOI Listing
August 2012

Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort.

Pharmacogenomics 2011 Jan;12(1):125-34

Department of Clinical Pharmacy, School of Pharmacy, 521 Parnassus Avenue, University of California, San Francisco, CA 94143-90622, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.168DOI Listing
January 2011

Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappaB and initiates tumour vascular normalization.

J Cell Mol Med 2009 Sep 11;13(9B):3993-4001. Epub 2009 May 11.

Oncogenic Signalling Laboratory, Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1582-4934.2009.00783.x
Publisher Site
http://dx.doi.org/10.1111/j.1582-4934.2009.00783.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516546PMC
September 2009

The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization.

Clin Cancer Res 2007 Mar;13(6):1911-25

Oncogenic Signalling Laboratory and Tumor Targeting Program, Ludwig Institute for Cancer Research, Melbourne Centre, Austin Hospital, Heidelberg, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1453DOI Listing
March 2007